Your browser doesn't support javascript.
loading
Improving quantification of anticholinergic burden using the Anticholinergic Effect on Cognition Scale - a healthcare improvement study in a geriatric ward setting.
Balasundaram, Bharathi; Ang, Wendy Swee Tee; Stewart, Robert; Bishara, Delia; Ooi, Chun How; Li, Fuyin; Akram, Farooq; Eu Kwek, Andrew Boon.
Afiliação
  • Balasundaram B; Department of Psychological Medicine, 26674Changi General Hospital, Singapore.
  • Ang WST; Department of Pharmacy, 26674Changi General Hospital, Singapore.
  • Stewart R; Department of Psychological Medicine, 34426Kings College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Bishara D; Department of Psychological Medicine, Kings College London, Institute of Psychiatry, Psychology and Neuroscience, Mental Health of Older Adults & Dementia, 4958South London & Maudsley NHS Foundation Trust, London, UK.
  • Ooi CH; Department of Geriatric Medicine, 26674Changi General Hospital, Singapore.
  • Li F; Advanced Practice Nurse Development, Department of Nursing, 26674Changi General Hospital, Singapore.
  • Akram F; Department of Internal Medicine, 26674Changi General Hospital, Singapore.
  • Eu Kwek AB; Department of Gastroenterology, 26674Changi General Hospital, Singapore.
Australas Psychiatry ; 30(4): 535-540, 2022 08.
Article em En | MEDLINE | ID: mdl-35726508
ABSTRACT

OBJECTIVE:

Anticholinergic burden refers to the cumulative effects of taking multiple medications with anticholinergic effects. This study was carried out in a public hospital in Singapore, aimed to improve and achieve a 100% comprehensive identification and review of measured, anticholinergic burden in a geriatric psychiatry liaison service to geriatric wards. We evaluated changes in pre-to post-assessment anticholinergic burden scores and trainee feedback.

METHOD:

Plan Do Study Act methodology was employed, and Anticholinergic Effect on Cognition scale (AEC) was implemented as the study intervention. A survey instrument evaluated trainee feedback.

RESULTS:

There was no measured anticholinergic burden in a baseline of 170 assessments. 75 liaison psychiatry assessments were conducted between June and November 2021 in two cycles. 94.7% of pre-assessments (at the time of assessment) and 71.1% of post-assessments (following assessment) had a record of AEC scores in clinical documentation in cycle one, improving in the second cycle to 100%, 94.6%, respectively. A high post-assessment AEC score of 3 and over reduced from 15.8% in cycle one to 5.4% in cycle two. The trainee feedback suggested an enriching educational experience.

CONCLUSIONS:

Using the AEC scale, the findings support the feasibility of comprehensive identification and review of measured anticholinergic burden in older people with neurocognitive disorders.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Cognitivos / Antagonistas Colinérgicos Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Cognitivos / Antagonistas Colinérgicos Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article